Opening Canada’s first Health Canada-approved supervised consumption sites

How Safe and Innovative Are First-in-Class Drugs Approved by Health Canada: A Cohort Study

INTRODUCTION First-in-class drugs use a unique mechanism of action. This study assessed the therapeutic innovativeness and safety of these drugs approved by Health Canada from 1997-2012. METHODS A list of new drugs was compiled and a database from the Food and Drug Administration was used to determine first-in-class status. Post-market safety warnings and drugs withdrawn for safety reasons we...

Longer Opening Hours , Alcohol Consumption and Health

Two related issues in public policy with respect to alcohol are how increased availability influences consumption and what effect excess consumption has on individual health outcomes. This paper examines one particular source of variation in availability, bar opening hours, and how this influences consumption, physical and mental health. We focus on the extension of opening hours in England and...

Supervised Injection Sites

Health care in Canada 2000: a first annual report.

CIHI is independent, national, and non-profit, and was established in 1994 by Canada’s national and provincial health ministers. It is expected to play a role in providing information both to health policy makers and the public at large. If this publication is a guide, it places more emphasis on the latter set of clients than does the AHIW. The style is straightforward with hardly any jargon, a...

Should North America’s first and only supervised injection facility (InSite) be expanded in British Columbia, Canada?

BACKGROUND This article reports qualitative findings from a sample of 31 purposively chosen injection drug users (IDUs) from Vancouver, Surrey and Victoria, British Columbia interviewed to examine the context of safe injection site in transforming their lives. Further, the purpose is to determine whether the first and only Supervised injection facility (SIF) in North America, InSite, needs to b...